Overview

Triazolam Trial In Healthy Subjects To Compare Bioavailability Between Formulations Of Triazolam To Determine Their Bioequivalence In Terms Of Rate And Magnitude Of Absorption

Status:
Withdrawn

Trial end date:
2010-09-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to compare the bioavailability of two oral formulations of Triazolam in healthy volunteers, in order to determine that they are bioequivalent.

Phase:

Phase 1

Details

Lead Sponsor:

Pfizer

Collaborator:

Investigación Farmacológica y Biofarmacéutica

Treatments:

Triazolam